SOW
OVID icon

State of Wyoming’s Ovid Therapeutics OVID Stock Holding History

State of Wyoming’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
53,438
+31,267
+141% +$80.7K 0.01% 1216
2026
Q1 		$49.2K Buy
+22,171
New +$39.6K 0.01% 1546
2023
Q3 		– Sell
-403
Closed -$1.32K – 1760
2023
Q2 		$1.32K Buy
403
+121
+43% +$411 ﹤0.01% 1511
2023
Q1 		$728 Sell
282
-11
-4% -$26 ﹤0.01% 1542
2022
Q4 		$545 Buy
293
+217
+286% +$370 ﹤0.01% 1523
2022
Q3 		$0 Buy
+76
New +$159 ﹤0.01% 1822

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State of Wyoming's OVID Position: Q2 2026 in Review

State of Wyoming increased its Ovid Therapeutics (OVID) stake by 141% in Q2 2026, buying an estimated $80.7K and bringing the position to 53,438 shares worth $144K. The position accounts for 0.01% of the portfolio, ranked #1216.

State of Wyoming first reported a position in OVID in Q3 2022 and has held it in 6 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • State of Wyoming held 53,438 shares of Ovid Therapeutics worth $144K as of Q2 2026.
  • State of Wyoming bought 31,267 Ovid Therapeutics shares in Q2 2026, an estimated $80.7K.
  • Ovid Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1216 holding.
  • State of Wyoming first reported a position in Ovid Therapeutics in Q3 2022 and has held it in 6 quarters since.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.